Malaria has yet remains one of the world’s most severe health problems, especially in regions across Africa and Asia. In 2012, malaria accounted for 627,000 deaths, and 91 percent of the deaths from malaria in 2010 were in Africa alone, according to the Center for Disease Control (CDC).
It might take a while to get this vaccine on the street, but the vaccine, Mosquirix, is safe for use in children aged 6 weeks to 17 months.
Mosquirix, also called RTS,S, helps protect against infection with the Plasmodium falciparum parasite, the deadliest of the four parasite species that infect humans and cause malaria. These vaccine aims to boost the immune system to fight the parasite, specifically to prevent the parasite from infecting the liver.
Typically, the parasite infects the liver first, multiplies there, and then re-enters the bloodstream to infect red blood cells, prompting symptoms to occur.
Mosquirix, also called RTS,S, helps protect against infection with the Plasmodium falciparum parasite, the deadliest of the four parasite species that infect humans and cause malaria. These vaccine aims to boost the immune system to fight the parasite, specifically to prevent the parasite from infecting the liver.
Typically, the parasite infects the liver first, multiplies there, and then re-enters the bloodstream to infect red blood cells, prompting symptoms to occur.
